Report: Medtronic's Ishrak takes home $25M in first year

Medtronic CEO took home $25 million in his first year--courtesy of Medtronic

In his first year as CEO of Medtronic ($MDT), Omar Ishrak pulled in a total compensation of $25 million, the Pioneer Press reports.

Ishrak joined Medtronic last year after serving as CEO of GE Healthcare, walking away from $16 million in stock-based pay in the process. This week's filing, however, shows that he has done pretty well for himself, regardless. Ishrak took in a base salary of $1.2 million, augmented by $1 million in incentives and about $23 million total in stock and awards, according to MassDevice.

Ishrak's haul is considerably higher than that of his predecessor, William Hawkins, who netted about $9.3 million--including a severance check--in his last year at Medtronic's helm. Much of the disparity comes in "make-whole" awards designed to compensate for the cash Ishrak left on the table at GE, but the other incentives were likely triggered by Medtronic's performance during his brief tenure.

The company reported revenue growth in three quarters of 2011, boosted by the big-selling Resolute stent and significant growth in diabetes-treating devices. Furthermore, the company is optimistic of its future with Ishrak. Medtronic is leading the race to get hypertension-treating techs onto U.S. shelves, and, with about $2 billion in hand, Ishrak has said the company is eyeing overseas acquisitions to further expand its market share.

- check out the SEC filing
- read the Pioneer Press report
- get more from MassDevice

Special Report: Top 10 Medical Device Industry CEO Salaries for 2011

Suggested Articles

BD will begin working with Babson Diagnostics to help bring its lab-quality device for collecting blood from capillaries into retail pharmacies.

The former CEO of the molecular testing company Foundation Medicine, Troy Cox, has been named chairman of the Swiss big data firm Sophia Genetics.

Researchers at MIT used a machine-learning algorithm to uncover the potent antibiotic properties hiding within an old small-molecule candidate.